actelion pharmaceuticals biotechnology company established december headquartered allschwil near basel actelion focuses manufacture drugs treat rare orphan diseases drugs produced used treat patients symptoms related central nervous system disorders irregular heart conditions immune system disorders one focuses actelion treating individuals pulmonary arterial hypertension pah heart condition leaves patients short life expectancy years even actelion scientists among first work field endothelian receptor actelion initially financed venture capital provided syndicate including atlas venture sofinnova healthcap actelion develops sells drugs continents asia europe north south actelion operative affiliates around world including united states canada brazil australia japan switzerland number eu countries swiss affiliate located baden german affiliate freiburg austrian one vienna french one paris uk affiliate located verification company established actelion endothelin research award program supports selected clinical research projectscitation needed january johnson johnson announced would purchase company actelions research development unit would also spun new company idorsia created former actelion drug discovery operations earlystage clinical development assets listed june six swiss johnson johnson announced would discontinue development one phase iii drugs acquired purchase actelion founded husband wife team jeanpaul martine together three colleagues f hoffmannla roche cut funding martines cardiovascular program founded actelion work drugs rare diseases retained rights intellectual property roche including molecule leading development tracleer drug treating pulmonary arterial hypertension pah became billion dollar cotherix biopharmaceutical company located south san francisco california cotherix focused licensing developing commercializing therapeutic products treatment cardiopulmonary chronic diseases company formerly known exhale therapeutics inc founded february gerard turino md past president american thoracic society jerome cantor md pulmonary pathologistcitation needed cotherixs commercial product ventavis iloprost inhaled therapy pulmonary artery hypertension pah approved united states food drug administration december two months companys initial public offering million shares common stock asahi developed fasudil entered licensing development agreement cotherix july pursue regulatory approval commercialization united states europe based prior track record november cotherix actelion signed merger plan subsequently announced publicly followed initiation negotiations august january actelion completed acquisition cotherix stock summarily informed asahi work fasudil would actelion competitor blockbuster drug market bosentan asashi claimed actelions acquisition cotherix directly aimed removing fasudil competitor therapeutic effectively asahi pursued damages cotherix actelion initially arbitration breach contract claim netted million jury trial resulted award million compensatory punitive case served exemplar notion companys contractual obligations persist companys november cotherix agreed purchased million cash actelion basel switzerland january deal closed actelion paying share cotherix stock actelion headquartered switzerland managed earn year reporting earning million swiss francs end accounting costs production raw materials wages company calculated operating margin operating profit net sales ratio tracleer one main drugs manufactured sold actelion used treat excessively high blood pressure affect arteries lungs heart years johnson johnson acquired pharmaceutical company actelion accused pushing prices tracleer according website known goodrx sixty tablets one months supply drug sold average actelion able illegally providing money medicare patients order able fulfill copayments drug medicare healthcare program adults years patients prescriptions covered medicare must still pay portion amount prescription known copayment making sure medicare patients still paying certain amount drug companies unable raise prices inordinately large however recently many large drug companies pfizer lundbeck united therapeutics actelion found illegally providing cash assistance charities help patients copayments order increase demand actelion able use charity organization name caring voice coalition send money people receiving prescriptions law enforcement able catch onto illegal activities occurring organization relation two pharmaceutical companies actelion united therapeutics banned partaking medicare related ignoring laws regulations set congress prevent pharmaceutical companies increasing demand prices drugs using information obtained caring voice coalition financially support patients buying drugs actelion able increase drug prices extraordinarily high amounts nearly inflation actelion also complicit referring patients caring voice coalition many unknowing patients gathering information organizations might cover medical needs sent cvc illegally furthering high demand investigations taking place actelion refused accept criminal activity misconduct occurred forced pay million settlement united states government malpractice relating kickbacks medicare october also caught two lawsuit drug buyers claimed actelion preventing generic version tracleer manufactured could stay charge market sole supplier analytics life company uses artificial intelligence develop solutions medical illnesses focusing efforts coronary artery disease actelion reported start working analytics life use imaging technology regards pulmonary study involving individuals conducted solve widespread companies hoping able accurately assess individuals cardiac health using imaging technology thus avoiding need invasive actelion hopes using technology help detect pulmonary hypertension people earlier age thus leading higher chances success treatment actelion currently compounds pipeline including latestage development medicines market orphan diseases drugs produced actelions provide pah pulmonary arterial hypertension market include latestage drugs development actelion include january actelion total employees research development sales marketing actelions sales amounted million actelions shares listed six swiss exchange ticker symbol atln since swx swiss exchange swiss leader index september actelion shares began trading part swiss market actelion received prix hermès de linnovation hermès award innovation april european institute creative strategy innovation creator prix hermès founded france performance report swiss pharma websites awarded actelion first prize second consecutive httpsenwikipediaorgwikicotherix